NHSBSP Publication No 49: clinical guidelines for healthcare professionals screening women for breast cancer.
Ref: NHSBSP Publication No 49; PHE publications gateway number: 2016426 PDF, 510KB, 36 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
The aim of assessment is to obtain a definitive and timely diagnosis of all potential abnormalities detected during screening.
This is best achieved by using ‘triple assessment’, comprising:
- imaging (usually mammography and ultrasound)
- clinical examination
- image guided needle biopsy for histological examination if indicated
Cytology should no longer be used alone to obtain a non-operative diagnosis of breast cancer.